CYTEGRITY Trademark

Trademark Overview


On Monday, August 19, 2019, a trademark application was filed for CYTEGRITY with the United States Patent and Trademark Office. The USPTO has given the CYTEGRITY trademark a serial number of 88583412. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2024. This trademark is owned by Calimmune, Inc.. The CYTEGRITY trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal...

Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research
cytegrity

General Information


Serial Number88583412
Word MarkCYTEGRITY
Filing DateMonday, August 19, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Goods and ServicesCell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders
Goods and ServicesCell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, September 4, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL BEHRING GENE THERAPY, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressTUSCON, AZ 85711

Party NameCalimmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711

Party NameCalimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711

Trademark Events


Event DateEvent Description
Monday, April 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023SOU EXTENSION 5 GRANTED
Tuesday, August 1, 2023SOU EXTENSION 5 FILED
Tuesday, August 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Saturday, February 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2023SOU EXTENSION 4 GRANTED
Thursday, February 2, 2023SOU EXTENSION 4 FILED
Thursday, February 2, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 2, 2022SOU EXTENSION 3 FILED
Tuesday, August 2, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 2, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 2, 2022SOU EXTENSION 2 FILED
Wednesday, February 2, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 28, 2021SOU EXTENSION 1 GRANTED
Wednesday, July 28, 2021SOU EXTENSION 1 FILED
Wednesday, July 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 2, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 23, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 23, 2020FINAL REFUSAL E-MAILED
Tuesday, June 23, 2020FINAL REFUSAL WRITTEN
Friday, June 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 3, 2020ASSIGNED TO LIE
Tuesday, May 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2019NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2019NON-FINAL ACTION WRITTEN
Tuesday, November 19, 2019ASSIGNED TO EXAMINER
Wednesday, September 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 22, 2019NEW APPLICATION ENTERED